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Abstract 
Lower urinary tract symptoms (LUTS), due to benign prostatic enlargement (BPE), are increasingly 
common, in the ageing male. A significant proportion of men will eventually progress with worsening 
symptoms or with the development of some form of complication secondary to bladder outlet obstruction, 
e.g. urinary retention. These men require surgical intervention. Transurethral resection of the prostate 
(TURP) is considered the reference standard surgical intervention for LUTS related to BPE.  Over the past 
decades, the TURP procedure has evolved due to numerous technical improvements and these 
developments, together with increasing surgical experience, are believed to have contributed to further 
improvements concerning post-operative functional outcomes, coupled with a decreased morbidity and 
mortality. The aims of this thesis were to explore and elucidate the effects of TURP, in a non-academic 
setting, including functional outcomes, complications and healthcare costs. All consecutive men subjected 
to a TURP procedure due to BPE at Skaraborgs Hospital during the periods 2010-2012 and 2017-2019 were 
identified and data retrieved from the hospital records. All men were followed-up for 3 months 
postoperatively and more if deemed necessary. Responders were defined according to criteria set up by de 
Wildt. Complications were graded according to the Clavien-Dindo system.  
In Paper I, men with bothersome LUTS and men in urinary retention reported response rates of 95% and 
83% respectively indicating that TURP is a successful procedure in both these patient categories.  
In Paper II, the incidence of major complications was low, during hospital stay (2.3%) and between 
hospital discharge and follow-up (3.4%). Late complications, requiring endourological re-intervention 
occurred in 9.7%.  
In Paper III, we followed the fate of the 35 non-responders and found that 11 men were finally judged to 
have satisfactory voiding parameters, 16 men utilized clean intermittent self-catheterisation to varying 
degrees, 7 men had to use an indwelling catheter indefinitely, and only one man still suffered from 
bothersome LUTS.  
In Paper IV, we analysed all in-hospital expenses of 122 men subjected to TURP and found that the median 
cost for this procedure was 37343 SEK (IQR 29852-44260). The main drivers of total cost were length of 
hospital stay, the surgical procedure and anaesthesia related costs. The main factor that increased total cost 
per patient was the occurrence of complications.  
In summary, TURP is a successful procedure in men with bothersome LUTS and in men with UR. 
Considering the difference regarding voiding outcomes in men operated on due to LUTS or UR, these 
groups should be analysed separately in future studies comparing TURP against newer treatment modalities. 
Men with preoperative urinary retention constituted the majority of non-responders. The use of 
postoperative urodynamic studies was remarkably low. Almost one in three non-responders finally had a 
satisfactory outcome with or without re-intervention. TURP in routine clinical practice was associated with 
a low incidence of severe complications. TUR syndrome was very rare. Within five years a small proportion 
of men require the transurethral intervention to be redone. However, the costs of a TURP procedure are 
strongly influenced by postoperative complications and all necessary means should be taken to avoid them 
from occurring. 
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